ReviewInflammopharmacology2026
Himalayan medicinal plants for gastrointestinal disorders: ethnopharmacology and mechanistic insights.
Review in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The Himalayan region has a rich and diverse flora specially of medicinal plants, many of which are traditionally used to treat various gastrointestinal (GI) disorders. GI disorders significantly contribute to global morbidity and mortality, and their prevalence is closely linked to dietary habits and lifestyle patterns. Since ancient times, plant-based or herbal medicines have played a crucial role in treating various ailments worldwide. Medicinal herbs are known to be rich sources of bioactive compounds with strong pharmacological and therapeutic potential. Numerous studies have reported the use of such plants for managing digestive disorders, highlighting their efficacy and minimal side effects compared to modern drugs. The growing preference for natural remedies has led to a renewed interest in exploring plant-based treatments for GI ailments. This review aims to compile and document twenty-nine medicinal plants found in the Himalayan region for the treatment of GI disorders, along with their active constituents, mechanisms of action, and supporting scientific evidence. These medicinal plants contain bioactive compounds like kaempferol, resveratrol, punicalagin, cinnamaldehyde, berberine, swertiamarin showing significant therapeutic potential. Experimental evidence from in vivo and in vitro studies suggest that these bioactive compounds exhibit antioxidant, anti-inflammatory, antimicrobial, anticancer and gastroprotective properties. These properties contribute to the therapeutic potential of Himalayan medicinal plants in treating GI disorders. Their traditional relevance, documented efficacy and limited clinical validation highlight the necessity of additional research and validation for successful integration into the modern healthcare systems.
Indexed as
Identifiers
42234313What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.